Solsten Diagnostics International ApS — Credit Rating and Financial Key Figures
CVR number: 40434704
Langdyssen 5, Lisbjerg 8200 Aarhus N
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 608.79 | 1 543.19 | 2 370.83 | 2 496.69 | 1 803.29 |
| Employee benefit expenses | -1 835.37 | -3 281.47 | -3 412.36 | -3 931.10 | -3 863.84 |
| Total depreciation | - 695.24 | - 833.21 | - 833.21 | - 938.87 | -2 011.39 |
| EBIT | -1 921.82 | -2 571.49 | -1 874.74 | -2 373.28 | -4 071.94 |
| Other financial income | 0.06 | 31.71 | 0.08 | ||
| Other financial expenses | - 110.94 | - 238.31 | - 303.29 | - 343.44 | - 429.15 |
| Pre-tax profit | -2 032.75 | -2 809.75 | -2 146.32 | -2 716.72 | -4 501.01 |
| Income taxes | 453.20 | 833.13 | 585.50 | 814.03 | 444.48 |
| Net earnings | -1 579.56 | -1 976.61 | -1 560.81 | -1 902.68 | -4 056.54 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 2 451.05 | 5 708.50 | 7 425.95 | 10 768.63 | 12 264.05 |
| Intangible rights | 2 571.43 | 2 142.86 | 1 714.29 | 1 285.71 | 857.14 |
| Intangible assets total | 5 022.48 | 7 851.35 | 9 140.23 | 12 054.34 | 13 121.19 |
| Machinery and equipment | 1 733.33 | 1 351.90 | 947.26 | 563.14 | 153.37 |
| Tangible assets total | 1 733.33 | 1 351.90 | 947.26 | 563.14 | 153.37 |
| Other receivables | 29.42 | 31.28 | |||
| Investments total | 29.42 | 31.28 | |||
| Long term receivables total | |||||
| Finished products/goods | 120.20 | 21.48 | |||
| Inventories total | 120.20 | 21.48 | |||
| Current trade debtors | 133.26 | ||||
| Current amounts owed by group member comp. | 849.73 | 1 617.46 | 1 206.39 | ||
| Prepayments and accrued income | 41.40 | 10.00 | |||
| Current other receivables | 125.84 | 75.38 | 144.28 | 203.02 | 221.73 |
| Current deferred tax assets | 849.73 | 1 275.24 | 1 206.39 | 1 067.12 | 330.85 |
| Short term receivables total | 975.57 | 2 241.75 | 3 111.38 | 2 476.53 | 552.58 |
| Cash and bank deposits | 293.59 | 232.94 | 304.19 | 135.21 | 198.90 |
| Cash and cash equivalents | 293.59 | 232.94 | 304.19 | 135.21 | 198.90 |
| Balance sheet total (assets) | 8 054.38 | 11 709.23 | 13 623.26 | 15 250.70 | 14 026.03 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Other reserves | 1 911.82 | 4 452.63 | 5 792.24 | 8 399.53 | 9 565.96 |
| Retained earnings | -1 911.82 | -6 032.19 | -9 348.41 | -13 516.51 | -16 585.62 |
| Profit of the financial year | -1 579.56 | -1 976.61 | -1 560.81 | -1 902.68 | -4 056.54 |
| Shareholders equity total | -1 529.56 | -3 506.17 | -5 066.98 | -6 969.66 | -11 026.20 |
| Provisions | 396.54 | 838.64 | 1 459.53 | 1 712.61 | 1 598.99 |
| Non-current other liabilities | 96.28 | 175.14 | 403.15 | ||
| Non-current deferred tax liabilities | 181.50 | 187.86 | |||
| Non-current liabilities total | 96.28 | 175.14 | 403.15 | 181.50 | 187.86 |
| Current trade creditors | 53.39 | 90.78 | 123.20 | 80.98 | |
| Current owed to group member | 8 798.72 | 13 586.43 | 15 676.43 | 19 332.91 | 22 830.93 |
| Other non-interest bearing current liabilities | 239.01 | 615.18 | 664.68 | -19 675.88 | -22 849.98 |
| Accruals and deferred income | 395.68 | 544.95 | 145.77 | ||
| Current liabilities total | 9 091.12 | 14 201.61 | 16 827.56 | 325.18 | 207.70 |
| Balance sheet total (liabilities) | 8 054.38 | 11 709.23 | 13 623.26 | -4 750.36 | -9 031.65 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.